NASDAQ: KOD
Kodiak Sciences Inc Stock

$4.99-0.35 (-6.55%)
Updated Feb 12, 2025
KOD Price
$4.99
Fair Value Price
$3.89
Market Cap
$262.59M
52 Week Low
$2.19
52 Week High
$11.60
P/E
-1.37x
P/B
1.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$191.62M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.01
Operating Cash Flow
-$119M
Beta
1.53
Next Earnings
Mar 26, 2025
Ex-Dividend
N/A
Next Dividend
N/A

KOD Overview

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine KOD's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

D
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
D
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
KOD
Ranked
#324 of 557

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important KOD news, forecast changes, insider trades & much more!

KOD News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how KOD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

KOD ($4.99) is overvalued by 28.29% relative to our estimate of its Fair Value price of $3.89 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
KOD ($4.99) is not significantly undervalued (28.29%) relative to our estimate of its Fair Value price of $3.89 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
KOD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more KOD due diligence checks available for Premium users.

Valuation

KOD fair value

Fair Value of KOD stock based on Discounted Cash Flow (DCF)

Price
$4.99
Fair Value
$3.89
Overvalued by
28.29%
KOD ($4.99) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
KOD ($4.99) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
KOD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

KOD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-1.37x
Industry
-144.01x
Market
37.75x

KOD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.42x
Industry
4.78x
KOD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

KOD's financial health

Profit margin

Revenue
$0.0
Net Income
-$43.9M
Profit Margin
0%
KOD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$372.7M
Liabilities
$187.3M
Debt to equity
1.01
KOD's short-term assets ($202.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KOD's short-term assets ($202.49M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KOD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
KOD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$21.2M
Investing
-$205.0k
Financing
$0.0
KOD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

KOD vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
KODD$262.59M-6.55%-1.37x1.42x
AVIRC$262.68M+4.01%-1.50x0.57x
TNGXD$264.25M-1.20%-2.12x1.15x
ABEOC$260.83M+6.19%-2.68x5.70x
YMABC$265.60M+2.77%-10.98x2.87x

Kodiak Sciences Stock FAQ

What is Kodiak Sciences's quote symbol?

(NASDAQ: KOD) Kodiak Sciences trades on the NASDAQ under the ticker symbol KOD. Kodiak Sciences stock quotes can also be displayed as NASDAQ: KOD.

If you're new to stock investing, here's how to buy Kodiak Sciences stock.

What is the 52 week high and low for Kodiak Sciences (NASDAQ: KOD)?

(NASDAQ: KOD) Kodiak Sciences's 52-week high was $11.60, and its 52-week low was $2.19. It is currently -56.98% from its 52-week high and 128.38% from its 52-week low.

How much is Kodiak Sciences stock worth today?

(NASDAQ: KOD) Kodiak Sciences currently has 52,623,774 outstanding shares. With Kodiak Sciences stock trading at $4.99 per share, the total value of Kodiak Sciences stock (market capitalization) is $262.59M.

Kodiak Sciences stock was originally listed at a price of $10.16 in Oct 4, 2018. If you had invested in Kodiak Sciences stock at $10.16, your return over the last 6 years would have been -50.89%, for an annualized return of -11.18% (not including any dividends or dividend reinvestments).

How much is Kodiak Sciences's stock price per share?

(NASDAQ: KOD) Kodiak Sciences stock price per share is $4.99 today (as of Feb 12, 2025).

What is Kodiak Sciences's Market Cap?

(NASDAQ: KOD) Kodiak Sciences's market cap is $262.59M, as of Feb 13, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Kodiak Sciences's market cap is calculated by multiplying KOD's current stock price of $4.99 by KOD's total outstanding shares of 52,623,774.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.